The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stoneformers.
D002118:Calcium / Q000652:urine*; D003460:Crystallization; D003461:Crystallography; D004032:Diet; D000431:Ethanol / Q000494:pharmacology / Q000627:therapeutic use; D006025:Glycosaminoglycans / Q000652:urine; D006801:Humans; D007669:Kidney Calculi / Q000188:drug therapy / Q000378:metabolism*; D063065:Organophosphonates / Q000494:pharmacology / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D010070:Oxalates / Q000494:pharmacology / Q000652:urine*; D014545:Urinary Calculi / Q000378:metabolism
D006025:Glycosaminoglycans; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D010070:Oxalates; D000431:Ethanol; D002118:Calcium